2Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量：214
3[1]Ryo K. Fas and Fas ligand strongly expressed in liver of fulninant hepatitis patients. Hepatology, 1995,22: 230A
4[2]Kiyoshi M, Norio H, Naoki H, et al. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatol, 1996,24:1 ～7
5[3]Knodell RG, lshak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology, 1981,1:431
6[4]Crespo J, Rivero M, Mayorga M, et al. Involvement of the Fas system in hepatitis C virus recurrence after liver transplantation.Liver Transplant, 2000,5: 562 ～ 569
7[5]Hodgson PD, Grant MD, Michalak TI. Perforin and Fas/Fas ligandmediated cytotoxicity in acute and chronic woodchuck viral hepatitis. Clin Exp Immunol, 1999, 118:63
8[6]Ryo K, Kamogawa Y, Ikeda I, et al. Significance of Fas antigen- mediated apoptosis in human fulminant hepatic failure. Am J Gastroenterol, 2000,8: 2047 ～ 2055
9Ciccocioppo R, Di Sabatino A, Parroni R, Muzi P, D'Alo S,Ventura T, Pistoia MA, Cifone MG, Corazza GR. Increased enterocyte apoptosis and Fas-Fas ligand system in celiac disease. Am J Clin Pathol 2001; 115:494-503.
10Demir G, Ozguroglu M, Sayhan N, Molinas-Mandel N,Demirelli F, Buyukunal E, Tuzuner N, Serdengecti S, Berkarda B. Immunomodulating therapy with rIL-2 and interferon alpha-induces in vivo expression of Bcl-2, Fas (APO-1/CD95),and Fas ligand on peripheral lymphocytes (a pilot study).Anticancer Res 1999; 19:3517-3520.
